---
figid: PMC6163961__medsci-06-00054-g004
figlink: /pmc/articles/PMC6163961/figure/medsci-06-00054-f004/
number: Figure 4
caption: Apoptosis inhibition in cancer. Schematic representation compiling some of
  the described mechanisms of apoptosis inhibition in cancer cells. Certain cancer
  cells have been observed to activate the PI3K-Akt pathway as survival mechanisms.
  In healthy cells and early-stage cancer cells, Transforming growth factor β (TGF-β)
  can induce cell-cycle arrest and apoptosis. However, there is evidence proving that
  in late-stage cancer cells, TGF-β can promote tumorigenesis, metastasis, and chemoresistance.
  Another described mechanism for cancer cell survival is the activation of the Ciclooxygenase
  2 (COX-2) pathway, which activated Akt and inhibits the overall antitumor effect
  of TGF-β in healthy cells or early-stage cancer cells.
pmcid: PMC6163961
papertitle: 'Apoptosis: Activation and Inhibition in Health and Disease.'
reftext: Sandra Georgina Solano-Gálvez, et al. Med Sci (Basel). 2018 Sep;6(3):54.
pmc_ranked_result_index: '12202'
pathway_score: 0.9711439
filename: medsci-06-00054-g004.jpg
figtitle: Apoptosis inhibition in cancer
year: '2018'
organisms: Homo sapiens
ndex: 24fb01ec-dec3-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6163961__medsci-06-00054-g004.html
  '@type': Dataset
  description: Apoptosis inhibition in cancer. Schematic representation compiling
    some of the described mechanisms of apoptosis inhibition in cancer cells. Certain
    cancer cells have been observed to activate the PI3K-Akt pathway as survival mechanisms.
    In healthy cells and early-stage cancer cells, Transforming growth factor β (TGF-β)
    can induce cell-cycle arrest and apoptosis. However, there is evidence proving
    that in late-stage cancer cells, TGF-β can promote tumorigenesis, metastasis,
    and chemoresistance. Another described mechanism for cancer cell survival is the
    activation of the Ciclooxygenase 2 (COX-2) pathway, which activated Akt and inhibits
    the overall antitumor effect of TGF-β in healthy cells or early-stage cancer cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BAD
  - AKT2
  - AKT3
  - PIK3R4
  - IRS1
  - PIK3CG
  - BAX
  - AKT1
  - SMAD9
  - PIK3CA
  - BCL2
  - PIK3CD
  - TGFB3
  - SMAD3
  - PIK3CB
  - PIK3R3
  - SMAD1
  - TGFB2
  - SMAD4
  - SMAD6
  - SMAD7
  - SART3
  - TGFB1
  - PIK3R5
  - TGFBR1
  - TGFBR2
  - PIK3R6
  - SMAD2
  - IRS4
  - IRS2
  - SMAD5
genes:
- word: Bad
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Bax
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Bcl-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: Smad3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: Smad4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD6
  entrez: '4091'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: TGF-BR1
  symbol: TGFBR1
  source: hgnc_symbol
  hgnc_symbol: TGFBR1
  entrez: '7046'
- word: TGF-BR2
  symbol: TGFBR2
  source: hgnc_symbol
  hgnc_symbol: TGFBR2
  entrez: '7048'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
chemicals: []
diseases: []
---
